These results are consistent with prior studies in our lab that demonstrated hyper-acetylation of SIRT3 targets in cardiac-specific FXN KO hearts, including AceCS2, LCAD, and MCAD [31]. The gene discussed is SIRT3; the disease is medium chain acyl-CoA dehydrogenase deficiency.